Question

Which of the following best describes Alzheimer’s disease?a. Alzheimer’s is a neurological disease with loss of memory and motor skills. b. Alzheimer’s occurs most often in people under the age of 40. c. Alzheimer’s is caused by toxins in the environment, rather than through genetic inheritance. d. Alzheimer’s only occurs in the elderly, and is expressed as shakes and tremors. e. Alzheimer’s only occurs in more developed countries, like the United States.

Answer 1

Answer:

Option (a).

Explanation:

Alzheimer’s disease may be defined as a medical condition that gets worse over time with age. Most of the dementia is caused by this disease. This is a type of inherited disease.

The Alzheimer’s disease is a neurological disorder. The individual starts feeling difficulty in remembering the small events. The disease is marked with loss of the motor skills and memory. The behavioral issue, motivation loss and mood swings are common in this disease.

Thus, the correct answer is option (a).

Answer 2

Answer:

A

Explanation:

Alzheimer's disease (AD) is a progressive and progressive neurological degenerative disease with clinical onset of memory impairment, aphasia, apraxia, misidentification, impaired visual skills, executive dysfunction, and personality and Behavioral changes such as general dementia are characterized, and the etiology is unknown.

Although pharmaceutical enterprises have maintained a high degree of enthusiasm for the development of AD new drugs, research and development activities of a new drug in this field have a very high failure rate, and in recent years, a series of new drugs entering Phase II or III clinical trials have failed. In addition, this disease lacks objective diagnostic criteria and biomarkers that can be used as clinical endpoints and efficacy criteria, which also poses a great challenge to the development of new drugs for AD. However, this disease is still one of the most active areas of new drug development. Moreover, considering the unmet clinical needs in the field of AD treatment, the FDA and other health administrations have provided strong support for the development of AD new drugs.

For more information: https://www.creativebiomart.net/alzheimacy/therapeutics/chemical-drug/